These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
349 related articles for article (PubMed ID: 32912726)
1. Systematic Review of the Effectiveness, Safety, and Acceptability of Mifepristone and Misoprostol for Medical Abortion in Low- and Middle-Income Countries. Ferguson I; Scott H J Obstet Gynaecol Can; 2020 Dec; 42(12):1532-1542.e2. PubMed ID: 32912726 [TBL] [Abstract][Full Text] [Related]
2. A cross-sectional analysis of mifepristone, misoprostol, and combination mifepristone-misoprostol package inserts obtained in 20 countries. Frye LJ; Kilfedder C; Blum J; Winikoff B Contraception; 2020 May; 101(5):315-320. PubMed ID: 32032639 [TBL] [Abstract][Full Text] [Related]
3. Low-dose mifepristone 200 mg and vaginal misoprostol for abortion. Schaff EA; Eisinger SH; Stadalius LS; Franks P; Gore BZ; Poppema S Contraception; 1999 Jan; 59(1):1-6. PubMed ID: 10342079 [TBL] [Abstract][Full Text] [Related]
4. Low-dose mifepristone followed by vaginal misoprostol at 48 hours for abortion up to 63 days. Schaff EA; Fielding SL; Eisinger SH; Stadalius LS; Fuller L Contraception; 2000 Jan; 61(1):41-6. PubMed ID: 10745068 [TBL] [Abstract][Full Text] [Related]
5. Safety, efficacy, and acceptability of medical abortion in China, Cuba, and India: a comparative trial of mifepristone-misoprostol versus surgical abortion. Winikoff B; Sivin I; Coyaji KJ; Cabezas E; Xiao B; Gu S; Du MK; Krishna UR; Eschen A; Ellertson C Am J Obstet Gynecol; 1997 Feb; 176(2):431-7. PubMed ID: 9065194 [TBL] [Abstract][Full Text] [Related]
6. Outcomes During Early Implementation of Mifepristone-Buccal Misoprostol Abortions up to 63 Days of Gestation in a Canadian Clinical Setting. Warden S; Genkin I; Hum S; Dunn S J Obstet Gynaecol Can; 2019 May; 41(5):647-652. PubMed ID: 31007171 [TBL] [Abstract][Full Text] [Related]
7. Medical termination for pregnancy in early first trimester (≤ 63 days) using combination of mifepristone and misoprostol or misoprostol alone: a systematic review. Abubeker FA; Lavelanet A; Rodriguez MI; Kim C BMC Womens Health; 2020 Jul; 20(1):142. PubMed ID: 32635921 [TBL] [Abstract][Full Text] [Related]
8. Can women in less-developed countries use a simplified medical abortion regimen? Elul B; Hajri S; Ngoc NN; Ellertson C; Slama CB; Pearlman E; Winikoff B Lancet; 2001 May; 357(9266):1402-5. PubMed ID: 11356438 [TBL] [Abstract][Full Text] [Related]
9. Mifepristone-misoprostol abortion: a trial in rural and urban Maharashtra, India. Coyaji K; Elul B; Krishna U; Otiv S; Ambardekar S; Bopardikar A; Raote V; Ellertson C; Winikoff B Contraception; 2002 Jul; 66(1):33-40. PubMed ID: 12169379 [TBL] [Abstract][Full Text] [Related]
10. Randomized trial of misoprostol and cervagem in combination with a reduced dose of mifepristone for induction of abortion. Baird DT; Sukcharoen N; Thong KJ Hum Reprod; 1995 Jun; 10(6):1521-7. PubMed ID: 7593528 [TBL] [Abstract][Full Text] [Related]
11. Acceptability and feasibility of outpatient medical abortion with mifepristone and misoprostol up to 70 days gestation in Singapore. Tan YL; Singh K; Tan KH; Gosavi A; Koh D; Abbas D; Winikoff B Eur J Obstet Gynecol Reprod Biol; 2018 Oct; 229():144-147. PubMed ID: 30179732 [TBL] [Abstract][Full Text] [Related]
12. Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion: A randomized trial. Schaff EA; Fielding SL; Westhoff C; Ellertson C; Eisinger SH; Stadalius LS; Fuller L JAMA; 2000 Oct; 284(15):1948-53. PubMed ID: 11035891 [TBL] [Abstract][Full Text] [Related]
13. Acceptability and feasibility of mifepristone medical abortion in the early first trimester in Azerbaijan. Louie KS; Tsereteli T; Chong E; Aliyeva F; Rzayeva G; Winikoff B Eur J Contracept Reprod Health Care; 2014 Dec; 19(6):457-64. PubMed ID: 25047120 [TBL] [Abstract][Full Text] [Related]
14. Risk factors for unsuccessful medical abortion with mifepristone and misoprostol. Haimov-Kochman R; Arbel R; Sciaky-Tamir Y; Brzezinski A; Laufer N; Yagel S Acta Obstet Gynecol Scand; 2007; 86(4):462-6. PubMed ID: 17486469 [TBL] [Abstract][Full Text] [Related]
15. Acceptability of suction curettage and mifepristone abortion in the United States: a prospective comparison study. Jensen JT; Harvey SM; Beckman LJ Am J Obstet Gynecol; 2000 Jun; 182(6):1292-9. PubMed ID: 10871441 [TBL] [Abstract][Full Text] [Related]
16. Combination of Mifepristone and Misoprostol for First-Trimester Medical Abortion: A Comprehensive Review of the Literature. Kelesidou V; Tsakiridis I; Virgiliou A; Dagklis T; Mamopoulos A; Athanasiadis A; Kalogiannidis I Obstet Gynecol Surv; 2024 Jan; 79(1):54-63. PubMed ID: 38306292 [TBL] [Abstract][Full Text] [Related]
17. Efficacy, Safety, and Acceptability of Low-Dose Mifepristone and Self-Administered Misoprostol for Ultra-Early Medical Abortion: A Randomized Controlled Trial. Li CL; Song LP; Tang SY; Zhou LJGY; He H; Mo XT; Liao YM Reprod Sci; 2017 May; 24(5):731-737. PubMed ID: 27678099 [TBL] [Abstract][Full Text] [Related]
18. Extending outpatient medical abortion services through 70 days of gestational age. Winikoff B; Dzuba IG; Chong E; Goldberg AB; Lichtenberg ES; Ball C; Dean G; Sacks D; Crowden WA; Swica Y Obstet Gynecol; 2012 Nov; 120(5):1070-6. PubMed ID: 23090524 [TBL] [Abstract][Full Text] [Related]
19. Termination of pregnancy at 9-13 weeks' amenorrhoea with mifepristone and misoprostol. Ashok PW; Flett GM; Templeton A Lancet; 1998 Aug; 352(9127):542-3. PubMed ID: 9716062 [TBL] [Abstract][Full Text] [Related]
20. Feasibility, efficacy, safety, and acceptability of mifepristone-misoprostol for medical abortion in the Democratic People's Republic of Korea. Tran NT; Jang MC; Choe YS; Ko WS; Pyo HS; Kim OS Int J Gynaecol Obstet; 2010 Jun; 109(3):209-12. PubMed ID: 20206354 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]